<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04966182</url>
  </required_header>
  <id_info>
    <org_study_id>2021-256</org_study_id>
    <nct_id>NCT04966182</nct_id>
  </id_info>
  <brief_title>Application CT and MRI in Cerebral Venous Sinus Thrombosis</brief_title>
  <official_title>the Application CT and MRI in the Diagnosis of Cerebral Venous Sinus Thrombosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral venous thrombosis (CVT) is a rare disease, and with poor prognosis. Computed&#xD;
      tomography (CT) andmagnetic resonance imaging (MRI) are the most commonly used image&#xD;
      modalities for patients with non-specific neurologic symptoms. We are going to assess the&#xD;
      accuracy of CT and MRI in the differential diagnosis of CVT and cerebral venous sinus&#xD;
      thrombosis (CVST).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>specificity and sensitivity of CT</measure>
    <time_frame>2022.01</time_frame>
    <description>specificity and sensitivity of CT in the diagnosis of cerebral venous sinus thrombosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>specificity and sensitivity of MRI</measure>
    <time_frame>2022.01</time_frame>
    <description>specificity and sensitivity of MRI in the diagnosis of cerebral venous sinus thrombosis</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Magnetic Resonance Imaging</condition>
  <condition>Cerebral Venous Sinus Thrombosis</condition>
  <condition>Computer Tomographgy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All the patients with the diagnosis of cerebral venous thrombosis or cerebral venous sinus&#xD;
        thrombosis at admission were included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A. The patients were diagnosed with cerebral venous thrombosis or cerebral venous sinus&#xD;
        thrombosis; B. The patients completed at least cranial CT or MRI examination upon&#xD;
        admission;C. The patients complete at least one of the CTV, MRV or DSA examination.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A. Patients with severe cardiopulmonary insufficiency;B. Patients lost to follow-up;C.&#xD;
        Patients with incomplete access to imaging data;D. Patients with cerebral venous sinus&#xD;
        thrombosis that was not diagnosed at discharge.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>xu weilin, Ph.D</last_name>
    <phone>+8618758140251</phone>
    <phone_ext>310000</phone_ext>
    <email>11618330@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>2nd Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>zexin chen, MD</last_name>
      <phone>+86 0571 87783759</phone>
      <email>keyanlunli_zheer@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 11, 2021</study_first_submitted>
  <study_first_submitted_qc>July 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>July 11, 2021</last_update_submitted>
  <last_update_submitted_qc>July 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinus Thrombosis, Intracranial</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

